chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: 0.25 ml from 2 vials with the same lot number was pulled up and administered as one dose; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of INCORRECT DOSE ADMINISTERED (0.25 ml from 2 vials with the same lot number was pulled up and administered as one dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced INCORRECT DOSE ADMINISTERED (0.25 ml from 2 vials with the same lot number was pulled up and administered as one dose). At the time of the report, INCORRECT DOSE ADMINISTERED (0.25 ml from 2 vials with the same lot number was pulled up and administered as one dose) had resolved. Unknown      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 01-Apr-2021: Follow up information was received on 01-Apr-2021 contains no new information.; Reporter's Comments: This report refers to a case of Inappropriate dose of vaccine administered for mRNA-1273, lot # 040A21A with no associated AEs.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Malaise, Myalgia, Pain in extremity
Clinical narrative: Do not feel good; No energy; Arm sore; Chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Do not feel good), ASTHENIA (No energy), PAIN IN EXTREMITY (Arm sore), CHILLS (Chills) and MYALGIA (Body aches) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 030M20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL AND HYDROCHLOROTHIAZIDE) and LEVOTHYROXINE SODIUM for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced MALAISE (Do not feel good), ASTHENIA (No energy), PAIN IN EXTREMITY (Arm sore), CHILLS (Chills) and MYALGIA (Body aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MALAISE (Do not feel good), ASTHENIA (No energy), PAIN IN EXTREMITY (Arm sore), CHILLS (Chills) and MYALGIA (Body aches) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Erythema, Eye pruritus, Pruritus, Rash
Clinical narrative: redness/erythema; red/itchy eyes; Rash across the stomach; Cold chills; Tremendously itchy skin; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Tremendously itchy skin), ERYTHEMA (redness/erythema), EYE PRURITUS (red/itchy eyes), RASH (Rash across the stomach) and CHILLS (Cold chills) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PRURITUS (Tremendously itchy skin) and CHILLS (Cold chills). On 27-Feb-2021 at 8:00 AM, the patient experienced RASH (Rash across the stomach). On an unknown date, the patient experienced ERYTHEMA (redness/erythema) and EYE PRURITUS (red/itchy eyes). The patient was treated with HYDROCORTISONE (topical) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) from 27-Feb-2021 to 03-Mar-2021 at an unspecified dose and frequency. On 03-Mar-2021, PRURITUS (Tremendously itchy skin) was resolving. On 03-Mar-2021 at 9:00 AM, RASH (Rash across the stomach) had resolved. At the time of the report, ERYTHEMA (redness/erythema) and EYE PRURITUS (red/itchy eyes) outcome was unknown and CHILLS (Cold chills) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.     This case was linked to MOD-2021-169853 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Updated reporter information. On 01-Jul-2021: significant follow up appended
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (very itchy where I got the shot) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (very itchy where I got the shot). At the time of the report, VACCINATION SITE PRURITUS (very itchy where I got the shot) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medication were included. Reporter denied further follow up.   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Follow up received on 20/05/2021 included TCR added/ Outcome of event updated.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Itchiness at the site of injection; Redness at the site of injection; Soreness at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection) and VACCINATION SITE PAIN (Soreness at the site of injection) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection) and VACCINATION SITE PAIN (Soreness at the site of injection). At the time of the report, VACCINATION SITE PRURITUS (Itchiness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection) and VACCINATION SITE PAIN (Soreness at the site of injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eating disorder, Headache, Nausea, Tremor
Clinical narrative: Has a hard time eating anything; Her whole body was shaking with chills; Chills; Headache; Nauseated; This spontaneous case was reported by a consumer and describes the occurrence of EATING DISORDER (Has a hard time eating anything), TREMOR (Her whole body was shaking with chills), CHILLS (Chills), HEADACHE (Headache) and NAUSEA (Nauseated) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced EATING DISORDER (Has a hard time eating anything), TREMOR (Her whole body was shaking with chills), CHILLS (Chills), HEADACHE (Headache) and NAUSEA (Nauseated). At the time of the report, EATING DISORDER (Has a hard time eating anything), TREMOR (Her whole body was shaking with chills), CHILLS (Chills), HEADACHE (Headache) and NAUSEA (Nauseated) outcome was unknown.            Concomitant medications included unspecified arthritis medicine.  No treatment details were provided by the reporter.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Legs broke out into a rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Legs broke out into a rash) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced RASH (Legs broke out into a rash). At the time of the report, RASH (Legs broke out into a rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Warm to hot; Itchy; Rash at injection site; Large red area at injection site, 4 by 5 inches like circle; Swollen; Little burning at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to hot), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash at injection site), VACCINATION SITE ERYTHEMA (Large red area at injection site, 4 by 5 inches like circle) and VACCINATION SITE SWELLING (Swollen) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D NOS for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE PAIN (Little burning at the injection site). On 10-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to hot), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash at injection site), VACCINATION SITE ERYTHEMA (Large red area at injection site, 4 by 5 inches like circle) and VACCINATION SITE SWELLING (Swollen). The patient was treated with DIPHENHYDRAMINE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Warm to hot), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash at injection site), VACCINATION SITE ERYTHEMA (Large red area at injection site, 4 by 5 inches like circle) and VACCINATION SITE SWELLING (Swollen) outcome was unknown and VACCINATION SITE PAIN (Little burning at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient informed that she was going to take a pill of topical diphenhydramine that night as treatment.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Warm to hot; Itchy; Rash at injection site; Large red area at injection site, 4 by 5 inches like circle; Swollen; Little burning at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to hot), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash at injection site), VACCINATION SITE ERYTHEMA (Large red area at injection site, 4 by 5 inches like circle) and VACCINATION SITE SWELLING (Swollen) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D NOS for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE PAIN (Little burning at the injection site). On 10-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to hot), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash at injection site), VACCINATION SITE ERYTHEMA (Large red area at injection site, 4 by 5 inches like circle) and VACCINATION SITE SWELLING (Swollen). The patient was treated with DIPHENHYDRAMINE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Warm to hot), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash at injection site), VACCINATION SITE ERYTHEMA (Large red area at injection site, 4 by 5 inches like circle) and VACCINATION SITE SWELLING (Swollen) outcome was unknown and VACCINATION SITE PAIN (Little burning at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient informed that she was going to take a pill of topical diphenhydramine that night as treatment.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Lymphadenopathy, Myalgia, Oropharyngeal pain, Pyrexia
Clinical narrative: Sore throat; Hot to touch injeciton site; Lump at the injection site; Swollen glands, lymph nodes in jaw swollen bilateral; Body aches; Swelling at the injection site; Pain at the injection site; Redness at and around the injection site; Fever 101.8; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), VACCINATION SITE WARMTH (Hot to touch injeciton site), VACCINATION SITE MASS (Lump at the injection site), LYMPHADENOPATHY (Swollen glands, lymph nodes in jaw swollen bilateral) and MYALGIA (Body aches) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), VACCINATION SITE WARMTH (Hot to touch injeciton site), VACCINATION SITE MASS (Lump at the injection site), LYMPHADENOPATHY (Swollen glands, lymph nodes in jaw swollen bilateral), MYALGIA (Body aches), VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE ERYTHEMA (Redness at and around the injection site) and PYREXIA (Fever 101.8). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, OROPHARYNGEAL PAIN (Sore throat), VACCINATION SITE WARMTH (Hot to touch injeciton site), VACCINATION SITE MASS (Lump at the injection site), LYMPHADENOPATHY (Swollen glands, lymph nodes in jaw swollen bilateral), MYALGIA (Body aches), VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE ERYTHEMA (Redness at and around the injection site) and PYREXIA (Fever 101.8) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, Body temperature: 101.8 (High) Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Sore throat; Hot to touch injeciton site; Lump at the injection site; Swollen glands, lymph nodes in jaw swollen bilateral; Body aches; Swelling at the injection site; Pain at the injection site; Redness at and around the injection site; Fever 101.8; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), VACCINATION SITE WARMTH (Hot to touch injeciton site), VACCINATION SITE MASS (Lump at the injection site), LYMPHADENOPATHY (Swollen glands, lymph nodes in jaw swollen bilateral) and MYALGIA (Body aches) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), VACCINATION SITE WARMTH (Hot to touch injeciton site), VACCINATION SITE MASS (Lump at the injection site), LYMPHADENOPATHY (Swollen glands, lymph nodes in jaw swollen bilateral), MYALGIA (Body aches), VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE ERYTHEMA (Redness at and around the injection site) and PYREXIA (Fever 101.8). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, OROPHARYNGEAL PAIN (Sore throat), VACCINATION SITE WARMTH (Hot to touch injeciton site), VACCINATION SITE MASS (Lump at the injection site), LYMPHADENOPATHY (Swollen glands, lymph nodes in jaw swollen bilateral), MYALGIA (Body aches), VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE ERYTHEMA (Redness at and around the injection site) and PYREXIA (Fever 101.8) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, Body temperature: 101.8 (High) Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Knock him out for a day; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Knock him out for a day) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in August 2020.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced FATIGUE (Knock him out for a day). On 19-Feb-2021, FATIGUE (Knock him out for a day) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness
Clinical narrative: Congested tight feeling in upper throat after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (Congested tight feeling in upper throat after 1st dose) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044a21a) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, LISINOPRIL, CARVEDILOL, PANTOPRAZOLE, ATORVASTATIN and MONTELUKAST for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced THROAT TIGHTNESS (Congested tight feeling in upper throat after 1st dose). At the time of the report, THROAT TIGHTNESS (Congested tight feeling in upper throat after 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment Information was reported.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Pain on right arm; Tested covid-19 positive after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain on right arm) and SARS-COV-2 TEST POSITIVE (Tested covid-19 positive after 1st dose) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025821A) for COVID-19 vaccination.     The patient's past medical history included Kidney stones, Heart racing and Cancer. Concomitant products included METOPROLOL and WARFARIN for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SARS-COV-2 TEST POSITIVE (Tested covid-19 positive after 1st dose). On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain on right arm). At the time of the report, PAIN IN EXTREMITY (Pain on right arm) and SARS-COV-2 TEST POSITIVE (Tested covid-19 positive after 1st dose) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Neck pain
Clinical narrative: Stiff neck pain, could not move; headache; describes the occurrence of NECK PAIN (Stiff neck pain, could not move) and HEADACHE (headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031/20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NECK PAIN (Stiff neck pain, could not move) and HEADACHE (headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, NECK PAIN (Stiff neck pain, could not move) and HEADACHE (headache) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medications were reported.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Fever; Headache; Muscle aches all over his body; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Muscle aches all over his body) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was  provided by the reporter.  Concomitant products included PRAVASTATIN for Cholesterol, LOSARTAN for Hypertension.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021 at 6:30 PM, the patient experienced PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Muscle aches all over his body). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. On 11-Mar-2021, PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Muscle aches all over his body) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Nausea, Pyrexia
Clinical narrative: dizziness; felt like she had to vomit; Low grade fever 101.9; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), NAUSEA (felt like she had to vomit) and PYREXIA (Low grade fever 101.9) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Osteoporosis. Concomitant products included CALCIUM PHOSPHATE DIBASIC, ERGOCALCIFEROL (VITAMIN D2 AND CALCIUM HYDROGEN PHOSPHATE) for Osteoporosis, RIVAROXABAN (XARELTO) and ATENOLOL for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced DIZZINESS (dizziness), NAUSEA (felt like she had to vomit) and PYREXIA (Low grade fever 101.9). At the time of the report, DIZZINESS (dizziness), NAUSEA (felt like she had to vomit) and PYREXIA (Low grade fever 101.9) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Body temperature: 101.9 (Inconclusive) Low grade fever 101.9.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided   This case was linked to MOD-2021-257168 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Non significant follow up received on 06-MAY-2021. Patient say's she could not figure out how to send the filled out ADR form. On 14-Jul-2021: No new information received
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Fatigue, Pain in extremity, Rash
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (sore arm), ERYTHEMA (arm is inflame, developed redness and an increment on local temperature), RASH (arm developed a rash between the shoulder and the elbow, kind of cellulitis), CHILLS (chills) and FATIGUE (tired) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021 at 7:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). 05-Feb-2021, the patient experienced CHILLS (chills) and FATIGUE (tired). On 06-Feb-2021, the patient experienced ERYTHEMA (arm is inflame, developed redness and an increment on local temperature) and RASH (arm developed a rash between the shoulder and the elbow, kind of cellulitis). At the time of the report, PAIN IN EXTREMITY (sore arm), ERYTHEMA (arm is inflame, developed redness and an increment on local temperature), RASH (arm developed a rash between the shoulder and the elbow, kind of cellulitis), CHILLS (chills) and FATIGUE (tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. For treatment patient reported applying cold compresses as palliative care.   This case was linked to MOD-2021-024720 (Patient Link).
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: Lower back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Lower back pain) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced BACK PAIN (Lower back pain). At the time of the report, BACK PAIN (Lower back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  The patient attributed the lower back pain might be due to poor sleeping position. On 12-Mar-2021, the patient received the second dose.  No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Breathing is off; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Breathing is off) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Pulmonary disorder.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced DYSPNOEA (Breathing is off). At the time of the report, DYSPNOEA (Breathing is off) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.  The patient stated in the follow up that she did not have a reaction first time.   Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: Follow up was received and no ne w information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Local tenderness at the injection site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (Local tenderness at the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, LEVOTHYROXINE and METFORMIN for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Local tenderness at the injection site). At the time of the report, VACCINATION SITE PAIN (Local tenderness at the injection site) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient has an unspecified underlying condition.  Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Nausea, Pyrexia, Rash, Vomiting
Clinical narrative: soreness; Nausea; fever; rash on arms, and back; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (soreness), NAUSEA (Nausea), PYREXIA (fever), RASH (rash on arms, and back) and VOMITING (Vomiting) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced ARTHRALGIA (soreness), NAUSEA (Nausea), PYREXIA (fever), RASH (rash on arms, and back) and VOMITING (Vomiting). At the time of the report, ARTHRALGIA (soreness), NAUSEA (Nausea), PYREXIA (fever), RASH (rash on arms, and back) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Treatment was reported as Tylenol, wet towels and diclofenac.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Numbness and tingling of the face, neck and shoulder; Numbness and tingling of the face, neck and shoulder; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness and tingling of the face, neck and shoulder) and PARAESTHESIA (Numbness and tingling of the face, neck and shoulder) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002H21A) for COVID-19 vaccination.     No medical history was reported.     On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Numbness and tingling of the face, neck and shoulder) and PARAESTHESIA (Numbness and tingling of the face, neck and shoulder). At the time of the report, HYPOAESTHESIA (Numbness and tingling of the face, neck and shoulder) and PARAESTHESIA (Numbness and tingling of the face, neck and shoulder) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant  information was  provided. No Treatment information was  provided.
Age: 100.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Rash
Clinical narrative: Swollen lip; Rash (on her arm, cross her chest, and legs); This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Swollen lip) and RASH (Rash (on her arm, cross her chest, and legs)) in a 100-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced LIP SWELLING (Swollen lip) and RASH (Rash (on her arm, cross her chest, and legs)). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at an unspecified dose and frequency. On 10-Mar-2021, LIP SWELLING (Swollen lip) had resolved. At the time of the report, RASH (Rash (on her arm, cross her chest, and legs)) had not resolved.            No concomitant medications was reported. Action taken with mRNA-1273 in response to the events was  not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Onset Date: ??-???-2021      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details were not provided.   Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-029064 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Faeces discoloured
Clinical narrative: 3x black stool; This spontaneous case was reported by an other and describes the occurrence of FAECES DISCOLOURED (3x black stool) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FAECES DISCOLOURED (3x black stool). At the time of the report, FAECES DISCOLOURED (3x black stool) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Insomnia
Clinical narrative: Felt lightheaded; couldn't sleep for exactly 12 hours; headachy; very tired; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (Felt lightheaded), INSOMNIA (couldn't sleep for exactly 12 hours), HEADACHE (headachy) and FATIGUE (very tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Felt lightheaded), INSOMNIA (couldn't sleep for exactly 12 hours), HEADACHE (headachy) and FATIGUE (very tired). At the time of the report, DIZZINESS (Felt lightheaded), INSOMNIA (couldn't sleep for exactly 12 hours), HEADACHE (headachy) and FATIGUE (very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and treatment information were not provided.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site rash, Vaccination site reaction
Clinical narrative: COVID arm; Felt like it was a little hard/harder than the other the arm; COVID arm/ quarter size of a cell phone; Light red in color; Pain all along/pain to the touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm), VACCINATION SITE INDURATION (Felt like it was a little hard/harder than the other the arm), VACCINATION SITE PAIN (Pain all along/pain to the touch), VACCINATION SITE RASH (COVID arm/ quarter size of a cell phone) and VACCINATION SITE ERYTHEMA (Light red in color) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus (on medication).    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain all along/pain to the touch). On 11-Mar-2021, the patient experienced VACCINATION SITE REACTION (COVID arm), VACCINATION SITE INDURATION (Felt like it was a little hard/harder than the other the arm), VACCINATION SITE RASH (COVID arm/ quarter size of a cell phone) and VACCINATION SITE ERYTHEMA (Light red in color). At the time of the report, VACCINATION SITE REACTION (COVID arm), VACCINATION SITE INDURATION (Felt like it was a little hard/harder than the other the arm), VACCINATION SITE PAIN (Pain all along/pain to the touch), VACCINATION SITE RASH (COVID arm/ quarter size of a cell phone) and VACCINATION SITE ERYTHEMA (Light red in color) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include medication for diabetes.  Treatment information was not provided
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: past the 42 day window; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (past the 42 day window) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011620A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (past the 42 day window). At the time of the report, PRODUCT DOSE OMISSION ISSUE (past the 42 day window) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased, Blood pressure measurement, Fatigue, Oxygen consumption decreased, Oxygen saturation
Clinical narrative: Drop in oxygen level; Drop in blood pressure; Really tired, layed down and went to sleep; This spontaneous case was reported by a consumer and describes the occurrence of OXYGEN CONSUMPTION DECREASED (Drop in oxygen level), BLOOD PRESSURE DECREASED (Drop in blood pressure) and FATIGUE (Really tired, layed down and went to sleep) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027LZ0A (possibly H) and 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced FATIGUE (Really tired, layed down and went to sleep). On 05-Feb-2021, the patient experienced OXYGEN CONSUMPTION DECREASED (Drop in oxygen level) and BLOOD PRESSURE DECREASED (Drop in blood pressure). At the time of the report, OXYGEN CONSUMPTION DECREASED (Drop in oxygen level), BLOOD PRESSURE DECREASED (Drop in blood pressure) and FATIGUE (Really tired, layed down and went to sleep) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Blood pressure measurement: 81/51 mmHg Low. On 05-Feb-2021, Oxygen saturation: 78 % Low. On 09-Feb-2021, Blood pressure measurement: mmHg Low. On 09-Feb-2021, Oxygen saturation: 87 % Low.          Treatment information included oxygen and discontinuation of blood pressure medicine. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-027684 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Dyspnoea, Headache, Hypertension
Clinical narrative: Difficulty breathing; High blood pressure; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), HYPERTENSION (High blood pressure) and HEADACHE (Headache) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN for an unknown indication.    On 11-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Difficulty breathing), HYPERTENSION (High blood pressure) and HEADACHE (Headache). At the time of the report, DYSPNOEA (Difficulty breathing), HYPERTENSION (High blood pressure) and HEADACHE (Headache) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Blood pressure measurement: increased (High) Increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow-up included: Denied consent for follow up.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Hypertension, Palpitations
Clinical narrative: High blood pressure; Fast heart rate; Chills; Fever 101.9; Joint pain; Fatigue; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High blood pressure), PALPITATIONS (Fast heart rate), CHILLS (Chills), PYREXIA (Fever 101.9) and ARTHRALGIA (Joint pain) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included BIOTIN, CURCUMA LONGA (TURMERIC [CURCUMA LONGA]), GLUCOSAMINE and OMEPRAZOLE for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). On 11-Mar-2021, the patient experienced HYPERTENSION (High blood pressure), PALPITATIONS (Fast heart rate), CHILLS (Chills), PYREXIA (Fever 101.9), ARTHRALGIA (Joint pain) and FATIGUE (Fatigue). At the time of the report, HYPERTENSION (High blood pressure), PALPITATIONS (Fast heart rate), CHILLS (Chills), PYREXIA (Fever 101.9), ARTHRALGIA (Joint pain), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included centrum.  No treatment information was provided.   This case was linked to MOD-2021-109516 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Updated reporter information and concomitant medication information.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: High blood pressure; Fast heart rate; Chills; Fever 101.9; Joint pain; Fatigue; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High blood pressure), PALPITATIONS (Fast heart rate), CHILLS (Chills), PYREXIA (Fever 101.9) and ARTHRALGIA (Joint pain) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included BIOTIN, CURCUMA LONGA (TURMERIC [CURCUMA LONGA]), GLUCOSAMINE and OMEPRAZOLE for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). On 11-Mar-2021, the patient experienced HYPERTENSION (High blood pressure), PALPITATIONS (Fast heart rate), CHILLS (Chills), PYREXIA (Fever 101.9), ARTHRALGIA (Joint pain) and FATIGUE (Fatigue). At the time of the report, HYPERTENSION (High blood pressure), PALPITATIONS (Fast heart rate), CHILLS (Chills), PYREXIA (Fever 101.9), ARTHRALGIA (Joint pain), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included centrum.  No treatment information was provided.   This case was linked to MOD-2021-109516 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Updated reporter information and concomitant medication information.